Drugs such as Ozempic and Mounjaro used to treat type 2 diabetes are gaining popularity and are prescribed by some for weight loss. needs. Dr. Michael Crawford discovered Mounjaro only recently, although he was diagnosed with type 2 diabetes four years ago. “It made a dramatic difference for me,” said Dr. Michael Crawford. Like Crawford, Elda Hernandez felt like she could really live her own life. “It’s really, really important to me. On a scale of 1 to 100 to 110,” Hernandez said. Medicine is very important to them. But lately they’ve been having trouble finding it. “I called 8, 9, 10 pharmacies and none had them. ‘ he says Mr Crawford. “Can you give me a prescription? My pharmacy didn’t have one, so the pharmacist came back and said, ‘No, I need it for my patient,'” Hernandez said. . It will be 1.5 hours before her pharmacy picks up the prescription. “It takes a few weeks for your body to adjust to the drug and for it to work,” Crawford said. “I’ve had two shortfalls, one for 10 days and one for 17 days, and each time I’ve been unable to resolve my quality of life issues, and I’ve suffered the consequences.” Crawford said, “The most frustrating part is why they can’t get it.” It’s what we’re prescribing to people who are trying to stay away and manage their disease progression,” Crawford said. Off label, for weight loss. Dr. Avin Pothuloori, Methodist Health System, is also an endocrinologist at Crawford & Hernandez. He is a member of the Endocrine Society’s Clinical Guidelines Committee. “Basically, we had to wait until supplies improved. Approved weight loss. This has led doctors to look for alternative prescriptions such as Ozempic and Mounjaro. However, both Ozempic and Mounjaro’s websites state that they are FDA-approved for diabetes, not just for weight loss. “It has helped me with my weight a little bit. But I’m not into it because of my weight. I don’t think so at this age.” “I’m not in for the weight. I’m in for the way it makes me feel.” Hernandez said. Pothuloori says you’ll usually put the weight back on as soon as you stop using the prescription, similar to crash dieting. “At the end of the day, these drugs are not without risks, and can be lifelong drugs for some people,” said Potrulli. He stresses that they are not FDA-approved for weight loss. Thanks to the drug, we will have a much better treatment for obesity,” said Pothulori.At this point, “we hope that eventually manufacturers will catch up in terms of demand. But in the short term, it shouldn’t be used off-label for weight loss,” said Crawford of Novo Nordisk. A spokesperson for Ozempic, the manufacturer, said, “All doses of Ozempic are now available in retail pharmacies nationwide for eligible type 2 diabetes patients. However, pharmacies experience the usual delays. “We are waiting to hear back from Eli Lilly, maker of Mounjaro. Omaha Summer 2024. Omaha City Council Permanently Fires Vinnie Palermo From Executive Position As Plans To Open Casino
Medications such as Ozempic and Mounjaro, used to treat type 2 diabetes, are becoming more popular as people begin to prescribe them for weight loss.
But some people with type 2 diabetes on the subway are having trouble finding injectables to meet their medical needs.
Dr. Michael Crawford was diagnosed with type 2 diabetes four years ago and only recently discovered Mounjaro.
“It made a dramatic difference for me,” said Dr. Michael Crawford.
Like Crawford, Elda Hernandez says she needs a drug called Ozempic to make her feel like she can really live her life.
“It’s really, really important to me. On a scale of 1 to 100 to 110,” Hernandez said.
Medicine is very important to them. But lately they’ve been having trouble finding it.
“I called 8, 9, 10 pharmacies and none had them. says Crawford.
“Can you give me a prescription? Because my pharmacy didn’t have one, so the pharmacist came back and said, ‘No, I need it for my patient,'” Hernandez said. .
It took Hernandez a month and a half to get the prescription from the pharmacy.
And that’s the weekly shot they need to stay on top of.
“It takes a few weeks for your body to adjust to the drug and for it to work,” Crawford said.
And if you miss those injections, Crawford says you can experience urinary and stomach problems, including severe diarrhea.
“I’ve had two shortfalls, one for 10 days and one for 17 days, and each time I’ve been unable to resolve quality of life issues and have suffered the consequences,” Crawford said.
The most frustrating part is why they can’t get it.
“The problem is that doctors are prescribing off-label drugs and keeping them out of the diabetes community and prescribing them to people who are trying to manage the progression of their disease,” Crawford said.
Off label, for weight loss.
Dr. Avin Pothuloori, Methodist Health System, is an endocrinologist at Crawford & Hernandez.
He is a member of the Endocrine Society’s Clinical Guidelines Committee.
They are not the only ones struggling to find injections, says Potuloli.
“Basically, we had to wait until supplies improved. Their diabetes is getting worse. In the meantime, we’re trying to get them to take other diabetes medications,” Pothulori said.
In 2021, he said, there was a shortage of Wegovy, a similar drug approved by the Food and Drug Administration for weight loss.
As such, doctors were looking for alternative prescriptions such as Ozempic and Mounjaro.
“The FDA says these drugs are not approved for weight loss. Pharmaceutical companies say these drugs are not approved for weight loss, but people can prescribe them. I got
Now they are very popular.
However, both the Ozempic and Mounjaro websites clearly point out that the FDA only approved diabetes, not weight loss.
And that’s all people like Crawford and Hernandez want.
“It’s helped me with the weight a little bit. But I’m not in it because of my weight. I don’t think that’s the case at this age. I’m not in it because of my weight. I don’t think it helps.” I’m in for the way it makes me feel,” Hernandez said.
Pothuloori says you’ll usually put the weight back on as soon as you stop using the prescription, similar to crash dieting.
“At the end of the day, these drugs aren’t without risks, and they can be lifelong drugs for some people,” Pothulori said.
Pothuloori still says we can see how the drug will change obesity treatments in the future.
But so far, he stresses, it’s not FDA-approved for weight loss.
“I think similar drugs will create competition. Similar drugs will come out. Thanks to these drugs, we will have better treatments for obesity,” Pothulori said.
Given an adequate supply, all three are fine for those who use the drug solely for weight loss.
But for now:
“Ultimately, we hope manufacturers will catch up in terms of demand. But in the short term, it shouldn’t be used off-label for weight loss,” Crawford said.
A spokesperson for Novo Nordisk, the manufacturer of Ozempic, said, “All doses of Ozempic are now available in retail pharmacies nationwide for people with suitable type 2 diabetes. Delays may occur: the time required to order products from local distribution centers and geographical differences.”
We would love to hear from Eli Lilly, the makers of Mounjaro.
top headline
